Characterizing the Private Sector in US Human Pathogen Research

Bloom JD , Chan YA , Baric RS , et al. Investigate the origins of COVID-19. Science. 2021; 372(6543):694.

Casadevall A , Shenk T . The H5N1 moratorium controversy and debate. mBio. 2012; 3(5):e00379-12.

Pannu J , Sandbrink JB , Watson M , Palmer MJ , Relman DA . Protocols and risks: when less is more. Nat Protoc. 2022; 17(1):1‐2.

Reardon S . ‘Forgotten’ NIH smallpox virus languishes on death row. Nature. 2014; 514(7524):544.

Sandbrink J , Ahuja J , Swett J , Koblentz G , Standley C . Mitigating biosecurity challenges of wildlife virus discovery. Preprint. SSRN. Posted February 17, 2022. Last revised September 7, 2022. Accessed June 11, 2024. https://dx.doi.org/10.2139/ssrn.4035760

Bünger M , Upton L . 4Q 2021 Synthetic Biology Venture Investment Report. Lafayette, CA: SynBioBeta; 2022. Accessed September 23, 2024. https://web.archive.org/web/20220213160905/http://uploads.builtwithbiology.com/BWB%20Q4%202021%20Final.pdf

Mervis J . Data check: U.S. government share of basic research funding falls below 50%. News from Science. Published March 9, 2017. Accessed June 12, 2024. https://www.science.org/content/article/data-check-us-government-share-basic-research-funding-falls-below-50

National Academies of Sciences, Engineering, and Medicine. Managing dual use research of concern. In: Dual Use Research of Concern in the Life Sciences: Current Issues and Controversies. Washington, DC: The National Academies Press; 2017:45‐72. Accessed June 12, 2024. https://doi.org/10.17226/24761

US Department of Health and Human Services (HHS). Framework for Guiding Funding Decisions About Proposed Research Involving Enhanced Potential Pandemic Pathogens. Washington, DC: HHS; 2017. Accessed June 12, 2024. https://www.phe.gov/s3/dualuse/Documents/P3CO.pdf

National Institutes of Health (NIH). NIH Guidelines for Research Involving Recombinant or Synthetic Nucleic Acid Molecules (NIH Guidelines). Bethesda, MD: NIH; 2024. Accessed September 23, 2024. https://osp.od.nih.gov/wp-content/uploads/NIH_Guidelines.pdf

Federal Select Agent Program. Select agents and toxins list. Last reviewed May 17, 2024. Accessed June 12, 2024. https://www.selectagents.gov/sat/list.htm

Shannon MJ . APHIS. In: Sharp JL , Hallman GJ , eds. Quarantine Treatments for Pests of Food Plants. Boca Raton, FL: CRC Press; 2019:1‐10.

National Research Council. Appendix A: OSHA laboratory standard. In: Prudent Practices in the Laboratory: Handling and Management of Chemical Hazards, Updated Version. Washington, DC: The National Academies Press; 2011:289‐305. Accessed June 12, 2024. https://doi.org/10.17226/12654

Cambridge Public Health Department. Laboratory biosafety. Updated June 8, 2023. Accessed June 12, 2024. https://www.cambridgepublichealth.org/laboratory-biosafety/

An Act Concerning Maryland Department of Health – Biosafety Level 3 Laboratories in Frederick County. S 450, 441st Leg (Maryland 2020). May 8, 2020. Accessed June 12, 2024. https://www.cityoffrederickmd.gov/DocumentCenter/View/18152/CLCAC-BSL3-Registration-Law

University of Connecticut Health, Office of the Vice President for Research. CT Department of Public Health (CT DPH) forms & checklists. Accessed March 22, 2024. https://ovpr.uchc.edu/services/rics/ehs/biosafety/ct-department-of-public-health-ct-dph-forms-checklists/

Prohibitions with Respect to Biological Weapons. 18 USC §175 (2018).

The Select Committee on the Chinese Communist Party (CCP). Investigation into the Reedley Biolab. Washington, DC: The Select Committee on the CCP; 2023. Accessed June 12, 2024. https://selectcommitteeontheccp.house.gov/sites/evo-subsites/selectcommitteeontheccp.house.gov/files/evo-media-document/scc-reedley-report-11.15.pdf

Bloom BR , Bloom J , Brownstein J , et al. Recommendations to strengthen the US Government’s enhanced potential pandemic pathogen framework and dual use research of concern policies. In: Compiled Public Comments on NIH Virtual Stakeholder Engagement Meeting on USG Policies for the Oversight of Life Sciences Dual Use Research of Concern. Bethesda, MD: National Institutes of Health; 2022:10‐18. Accessed December 23, 2022. https://osp.od.nih.gov/wp-content/uploads/2023/05/Written_Comments_12_July_2022.pdf

National Science Advisory Board for Biosecurity (NSABB). Proposed Biosecurity Oversight Framework for the Future of Science. Bethesda, MD: NSABB; 2023. Accessed June 12, 2024. https://osp.od.nih.gov/wp-content/uploads/2023/03/NSABB-Final-Report-Proposed-Biosecurity-Oversight-Framework-for-the-Future-of-Science.pdf

Gillum D , Wyneken H , Fletcher J , Nubbe K , Vogel KM . Experiences during the COVID-19 pandemic: a survey of biosafety professionals. Appl Biosaf. 2022; 27(3):127‐143.

Gryphon Scientific LLC . Characterizing Private-Sector Research on Human Pathogens in the United States, Takoma Park, MD: Gryphon Scientific, LLC, 2023. Accessed September 18, 2024. https://pandorareport.org/gryphon-scientific-characterizing-private-sector-research-on-human-pathogens-in-theunited-states-july-2023-funded-by-open-philanthropy/

Greene D , Palmer MJ , Relman DA . Motivating proactive biorisk management. Health Secur. 2023; 21(1):46‐60.

Perkins D , Danskin K , Rowe AE , Livinski AA . The culture of biosafety, biosecurity, and responsible conduct in the life sciences: a comprehensive literature review. Appl Biosaf. 2019; 24(1):34‐45.

Race MS , Hammond E . An evaluation of the role and effectiveness of institutional biosafety committees in providing oversight and security at biocontainment laboratories. Biosecur Bioterror. 2008; 6(1):19‐35.

Schröder I , Huang DYQ , Ellis O , Gibson JH , Wayne NL . Laboratory safety attitudes and practices: a comparison of academic, government, and industry researchers. J Chem Health Saf. 2016; 23(1):12‐23.

Ritterson R , Kingston L , Fleming AEJ , Lauer E , Dettmann RA , Casagrande R . A call for a national agency for biorisk management. Health Secur. 2022; 20(2):187‐191.